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To the Editor: 
Worldwide, only 10% of the approximately 1.7 million dialysis patients are treated with 
home-based peritoneal dialysis (PD); the majority receive facility-based hemodialysis (HD) even 
though most patients prefer PD when educated about their options.(1) There is substantial 
geographic variation in PD utilization. Between-country variation may result from cost of 
treatments, cultural, educational, and healthcare system differences, or reimbursement policies 
that incentivize the use of one therapy.  Within-country variation may reflect regional differences 
in facility infrastructure, expertise, resources, and home dialysis education. 
Physician education, training, and experience with home PD remains limited. A recent 
survey identified home dialysis training as the leading educational gap among United States 
nephrologists in training.(2) Although few absolute contraindications to PD exist, 
recommendations to more challenging patients can vary. This may stem from a lack of comfort 
with PD as a therapy or an inherent negative perception regarding its suitability.  
We compared differences in attitudes of the medical directors of both PD and in-center 
HD units towards patient eligibility and the barriers to PD utilization. We hypothesized that 
regardless of country, by virtue of limited exposure, the leaders of HD facilities may employ 
more restrictive and varied eligibility criteria and perceive different barriers to PD use compared 
to their PD counterparts. 
 We examined 2014-2018 data from the Dialysis Outcomes and Practice Patterns Study 
(DOPPS) Phases 5-6 and Peritoneal DOPPS (PDOPPS) Phase 1. The DOPPS and PDOPPS 
are ongoing, international prospective cohort studies of dialysis facility practices and patient 
outcomes for adult in-center HD and PD participants. Study participants are ≥ 18 years and 
selected randomly from a national sample of dialysis facilities patients 
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(http://www.dopps.org).(3, 4) A central IRB approved each study phase; we obtained additional 
approvals and informed patient consents as required by national and local regulations. 
The DOPPS asked medical directors of PD and HD facilities in Canada, Japan, the 
United Kingdom (UK), and the US: 1) to rate the level of PD training and support in their units, 
2) whether certain patient factors would influence PD recommendations, and 3) potential 
reasons why PD was not more widely used in their program. 
One hundred eighty-five (73% response rate) HD and 116 (66% response rate) PD 
directors responded. PD directors perceived greater PD training and enthusiasm among their 
nephrologists and nursing staff (72%-97% vs. 69%-84%). HD directors were much less likely to 
recommend PD for patients across a host of conditions and patient characteristics (Figure 1A).  
HD and PD directors held different opinions about the reasons for low PD use in their 
programs (Figure 1B). Most PD directors believed that closely locating PD units impedes 
growth, and that the perception of HD’s superior quality contributed to low PD use. Fewer than 
half of HD directors agreed with those statements; they were more likely to cite patient 
preferences such as comfort with, and fears about PD as the cause of lower use. The only 
major inter-country variation we noted was in Japan—staff in these HD units were generally the 
least enthusiastic about PD (35-40% vs. 61-100% in other countries). 
It is troubling that these beliefs translate into strikingly wide gaps in recommending PD 
for incident patients with common co-morbid conditions. Half of US patients starting dialysis 
have diabetes, a quarter are aged 75 or older, and a third are obese. Choosing not to consider 
PD for these patients will restrict their choice of modality, a decision more appropriately based 
on broader clinical and patient-centered outcomes such as quality of life. 
HD medical directors’ responses also indicated misconceptions about PD eligibility. They 
may have been unfamiliar with the option of assisted PD for patients traditionally viewed as poor 
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candidates, or less current with literature that has refuted the myths that minor surgeries, 
polycystic kidney disease, or impending transplant are contraindications to PD. Physicians may 
also steer patients with a functioning fistula or graft towards HD. 
HD medical directors were more likely to cite patient preferences as a barrier to PD use, 
a view potentially influenced by interaction with patients who have chosen HD over PD. 
Physicians’ belief that patients prefer HD may consciously or unconsciously alter their approach 
to presenting PD as a treatment option. 
Improved personnel education has the potential to reduce bias against home dialysis in 
HD units. A three-hour education initiative improved the attitudes of in-center HD nurses 
towards home dialysis.(5) Similar interventions for HD-focused physicians may catalyze PD 
growth.  
Another solution involves creation of dedicated transitional care units that provide 
incident dialysis patients with the comprehensive support and unbiased education they need to 
make an informed modality choice.(6) This is especially salient among patients urgently starting 
dialysis. Many “crash start” patients initiate HD by default without the opportunity to be 
adequately informed. In the US, 18% of PD medical directors cited the high number of acute, in-
hospital dialysis starts as a top barrier to PD growth. Once patients are established in traditional 
HD centers, education about treatment options may be limited and delivered by personnel who 
may strongly favor HD.(5)  
Study limitations include that physician opinions may not reflect actual practice, and 
results may not be generalizable to the excluded directors who practice in units with less than 
either 20 PD or HD patients and to countries not included in the survey. We also did not quantify 
PD exposure and expertise among respondents and surveyed on select barriers, which did not 
include physician reimbursement policies.  
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Notwithstanding these limitations, HD medical directors had staff with less training in and 
enthusiasm for PD, were less likely to recommend PD, and more likely to cite patient preference 
as a barrier to PD growth. Educating physicians and staff, particularly about PD feasibility 
among various patients, may lead to greater utilization. The addition of transitional care units to 
ensure complete and unbiased patient education would help support informed modality decision 
making, particularly for those unexpectedly starting dialysis. Only through a multi-pronged 
solution that engages a range of practitioners can we expect to see major gains in PD use.  
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Figure Legend 
Figure 1. Patient conditions and other reasons for PD underutilization. 
The survey question was:  
A) “How likely are you to discourage the use of peritoneal dialysis based on the following 
conditions alone?”  
Footnote: 116 MD in PD facilities (Canada 15, Japan 25, UK 34, and US 42), and 185 MD in HD 
facilities responded (Canada 25, Japan 61, UK 20, and US 79). Answer choices for HD MDs 
were: Much more likely to recommend, Somewhat more likely to recommend, Remain neutral, 
Somewhat less likely to recommend, and Much less likely to recommend; while for PD MDs 
were: Strongly encourage, Encourage, Remain neutral, Discourage, and Strongly discourage. 
 
B) “The following questions refer to the reasons PD is not more widely used at your program. 
Answer your level of agreement with the following.” 
Footnote: 116 MD in PD facilities (Canada 15, Japan 25, UK 34, and US 42), and 185 MD in HD 
facilities responded (Canada 25, Japan 61, UK 20, and US 79). Answer choices were the same 
for both groups were: Strongly disagree, Disagree, Neither agree nor disagree, Agree, and 
Strongly agree.  
9 
 
 
Figure 1A  
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Figure 1B 
 
 
